Life science investors and corporate finance

Urgent reimbursement analysis within 2 weeks to support Med Tech and In-Vitro Diagnostics acquisition decisions

What is included in our reimbursement due diligence report?

Openness of EU markets to technology

Current uptake of technology

Current reimbursement levels

Restrictions in technology use by health authorities (indications, size of population)

Pathways, timelines and requirements to establish sufficient reimbursement

Contact us to request example of the reimbursement report

Our services cover 18 European countries, including Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden and Switzerland

We provide services for major types of medical technologies

Implantable devices

Interventional procedures

Non-interventional procedures

Medical aids

In-vitro diagnostic tests

Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, endoscopy and more

Check out our database of off-the-shelf reimbursement reports for medical technologies in 11 European countries

Released reports:

  • 3D conformal radiation therapy
  • Ablation of heart tissue for atrial fibrillation
  • Angioplasty of arteries of lower extremities for peripheral artery disease
  • Atherectomy for peripheral artery disease
  • Brachytherapy
  • Combined report for minimally invasive and transcatheter mitral valve repair and replacement procedures for mitral regurgitation
  • Coronary imaging and diagnostic procedures
  • Coronary percutaneous revascularization procedures
  • Extra-corporeal membrane oxygenation (ECMO) for pulmonary and cardiac failure
  • Image-guided radiotherapy
  • Intensity modulated radiotherapy (IMRT)
  • Mechanical thrombectomy for acute ischemic stroke
  • Minimally-invasive mitral valve repair with creation of artificial chordae tendonae for mitral regurgitation
  • Minimally-invasive replacement of mitral valve for mitral regurgitation
  • Minimally-invasive reshaping of heart geometry for mitral regurgitation
  • Percutaneous ablation procedures for diseases of lung, prostate, kidney, liver and bone
  • Percutaneous procedures for deep vein thrombosis
  • Proton Therapy
  • Robotic surgery interventions
  • Spinal cord stimulation
  • Stereotactic body radiation therapy
  • Stereotactic Radiosurgery
  • Surgical and endovascular treatment of brain aneurysm
  • Transcatheter annuloplasty ring for mitral regurgitation
  • Transcatheter aortic valve implantation (TAVI)
  • Transcatheter mitral annuloplasty using implant placed in the coronary sinus for mitral regurgitation
  • Transcatheter mitral valve leaflet repair using mitral clips for mitral regurgitation
  • Transcatheter mitral valve repair using mitral annulus plication for mitral regurgitation
  • Transcatheter mitral valve replacement
  • Vascular access for long-term use: AV fistula and AV graft
  • Ventricular assist devices for circulatory support
  • Volumetric modulated arc therapy (VMAT)

Ongoing reports:

  • Balloon sinus dilation for chronic sinusitis
  • Bariatric surgery
  • Capsule endoscopy
  • Cardiac pacemakers
  • Cardiac resynchronization therapy
  • Computed tomography in ambulatory settings
  • Cochlear implants for hearing loss
  • Deep brain stimulation
  • Endovascular repair (EVAR) of abdominal aortic aneurysm (AAA)
  • Gastric electrical stimulation for gastroparesis and obesity
  • Hernia repair
  • Hospital and out-patient remote monitoring coding and reimbursement for neurostimulators
  • Implantable cardioverter defibrillators (ICDs)
  • Inferior Vena Cava Filter
  • Lung volume reduction for emphysema
  • Magnetic resonance imaging in ambulatory settings
  • Minimally invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)
  • Open replacement of heart valves (all valves)
  • Peripheral intravascular ultrasound
  • Vagus nerve stimulation

Confidence in results

We  have established  numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:

  • Standard Operating Procedures and Work Instructions
  • Access to official coding and DRG manuals, tariff lists and grouping software
  • A team, comprised of experienced Clinical Coders with a medical background
  • Quick access to health authorities to address uncertainties
  • Ongoing research program to get insights from payer and provider interviews
  • All reports are reviewed by the CEO before release

Get analysis results within 2 weeks

  • Our standard turnaround time for reimbursement due diligence projects is only 2 weeks
  • During the project you have 24/7 access to the project manager so as to get all the necessary support

Are you interested in learning more about how we can help you?